Reneo Pharmaceuticals Inc.

13F holders, Q3 2024 (September 30)
50holders −16
6new positions
22sold out
3famous investors
$1.70avg. 13F price*

At the end of Q3 2024, 50 institutions reported holding Reneo Pharmaceuticals Inc. in their 13F filings, down 16 from Q2 2024. 6 opened new positions and 22 sold out. The largest holders were NEA Management Company, LLC ($8.1M), BML Capital Management, LLC ($5.9M) and Highbridge Capital Management LLC ($5.2M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Reneo Pharmaceuticals Inc.
CUSIP
75974E103
Latest filing quarter
Q4 2025

History

Number of 13F holders

020406080 Q1 2024: 62Q1 2024Q2 2024: 66Q2 2024Q3 2024: 50Q3 2024Q4 2025: 1Q4 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions6$1.9M
Exits22$782K

All 13F filers, Q2 2024 → Q3 2024: 2,651,256 shares bought and 1,019,924 shares sold, net +1,631,332 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 50 holders

NEA Management Company, LLC 0.44% No change 4,785,494 $8.1M
BML Capital Management, LLC 3.46% Add +29.4% 3,457,395 $5.9M
Highbridge Capital Management LLC 0.91% Add +5.0% 3,062,690 $5.2M
Tang Capital Management LLC 0.36% Reduce -1.7% 2,946,260 $5.0M
Carlyle Group Inc. 0.48% No change 2,698,957 $4.5M
RiverVest Venture Management LLC 63.00% No change 2,534,220 $4.3M
Octagon Capital Advisors LP 0.61% No change 2,250,000 $3.8M
Ikarian Capital, LLC 0.54% New 1,025,668 $1.7M
Aisling Capital Management LP 0.58% No change 886,075 $1.5M
Vanguard Group Inc. 0.00% No change 882,104 $1.5M
Vestal Point Capital, LP 0.11% Add +46.7% 799,400 $1.4M
Nantahala Capital Management, LLC 0.08% No change 547,804 $931K
Renaissance Technologies 0.00% Add +13.4% 501,534 $853K
Aldebaran Capital, LLC 0.70% Add +1.0% 452,116 $769K
Acuitas Investments, LLC 0.31% Reduce -0.8% 403,148 $685K
Two Sigma Advisers, LP 0.00% Add +202.1% 226,300 $385K
BlackRock, Inc. 0.00% — 221,325 $376K
Geode Capital Management, LLC 0.00% Add +6.7% 214,499 $365K
Two Sigma Investments, LP 0.00% Add +21.0% 135,326 $230K
Millennium Management 0.00% Add +9.6% 120,565 $205K
Citadel Advisors 0.00% Add +751.9% 92,913 $158K
JBF Capital, Inc. 0.02% No change 80,000 $136K
Marquette Asset Management, LLC 0.02% No change 73,770 $125K
State Street Corp. 0.00% No change 71,636 $122K
Morgan Stanley 0.00% Reduce -67.5% 64,523 $110K
Bank of Montreal 0.00% Reduce -53.6% 60,617 $101K
Ameriprise Financial Inc. 0.00% New 49,824 $85K
Northern Trust Corp. 0.00% Reduce -62.7% 44,013 $75K
Shay Capital LLC 0.01% New 28,617 $49K
Tower Research Capital LLC (TRC) 0.00% Add +36.0% 20,311 $35K
Commonwealth Equity Services, LLC 0.00% No change 19,347 $33K
Goldman Sachs Group Inc. 0.00% Reduce -90.2% 14,135 $24K
Dimensional Fund Advisors LP 0.00% No change 13,327 $23K
Squarepoint Ops LLC 0.00% Reduce -43.4% 11,034 $19K
Point72 Asia (Singapore) Pte. Ltd. 0.00% Reduce -46.4% 9,668 $16K
Russell Investments Group, Ltd. 0.00% Add +124.0% 9,520 $16K
JPMorgan Chase & Co. 0.00% Reduce -3.2% 7,668 $13K
China Universal Asset Management Co., Ltd. 0.00% Add +63.7% 6,429 $11K
Citigroup Inc. 0.00% Reduce -59.0% 3,554 $6K
Osaic Holdings, Inc. 0.00% New 1,526 $3K
Bank of America Corp. 0.00% Add +28.0% 1,212 $2K
Wells Fargo & Company 0.00% No change 1,200 $2K
UBS Group AG 0.00% Reduce -89.4% 1,189 $2K
Mirae Asset Global Investments Co., Ltd. 0.00% Add +21.1% 1,209 $2K
Cornerstone Planning Group LLC 0.00% New 53 $947
Cubist Systematic Strategies, LLC 0.00% Reduce -86.1% 533 $906
Group One Trading LLC 0.00% Reduce -91.5% 502 $853
Barclays PLC 0.00% Add +395.6% 228 $389
Arax Advisory Partners 0.00% No change 171 $291
Simplex Trading, LLC 0.00% New 100 $0

"% of holder's portfolio" is RENEO PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Reneo Pharmaceuticals Inc. the manager owns.